Entering text into the input field will update the search result below

Biota Pharma reports fiscal year results

Sep. 30, 2014 3:38 PM ETVaxart, Inc. (VXRT) StockBy: Douglas W. House, SA News Editor
  • Biota Pharmaceuticals (BOTA -0.8%) financial results:
  • Fiscal Q4: Revenues: $8.5M (-8.6%); Operating Expenses: $19.0M (+21.0%); Operating Loss: ($10.5M) (-64.1%); Net Loss: ($10.2M) (-56.9%); Loss Per Share: ($0.29) (-26.1%); Quick Assets: $81.7M (+22.3%).
  • Fiscal 2014: Revenues: $68.7M (+104.5%); Operating Expenses: $80.2M (+44.0%); Operating Loss: ($11.5M) (+48.0%); Net Loss: ($11.0M) (-23.6%); Loss Per Share: ($0.35) (-9.4%).
  • No financial guidance given.

Recommended For You

More Trending News

About VXRT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
VXRT--
Vaxart, Inc.